Patents by Inventor Miguel Ramón Campanero Garcia

Miguel Ramón Campanero Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IN VITRO METHOD FOR IDENTIFYING THORACIC AORTIC ANEURYSMS (TAA) IN A SUBJECT
    Publication number: 20210363501
    Abstract: The present invention refers to an In vitro method for screening for subjects at risk of developing thoracic aortic aneurysm (TAA) or a disease causing TAA comprising: (a) measuring the expression pattern or level of at least A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 (ADAMTS1) obtained from an isolated biological sample of the subjects to be screened; and (b) comparing said expression pattern or level of at least ADAMTS1 of the subjects to be screened with an already established expression pattern or level, wherein reduced expression of at least ADAMTS1 is indicative of a thoracic aortic aneurysm (TAA).
    Type: Application
    Filed: December 15, 2020
    Publication date: November 25, 2021
    Inventors: Juan Miguel Redondo Moya, Nerea MÉNDEZ-BARBERO, Jorge Oller Pedrosa, Miguel Ramón Campanero Garcia
  • In vitro method for identifying thoracic aortic aneurysms (TAA) in a subject
    Patent number: 10907135
    Abstract: The present invention refers to an In vitro method for screening for subjects at risk of developing thoracic aortic aneurysm (TAA) or a disease causing TAA comprising: (a) measuring the expression pattern or level of at least A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 (ADAMTS1) obtained from an isolated biological sample of the subjects to be screened; and (b) comparing said expression pattern or level of at least ADAMTS1 of the subjects to be screened with an already established expression pattern or level, wherein reduced expression of at least ADAMTS1 is indicative of a thoracic aortic aneurysm (TAA).
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: February 2, 2021
    Assignees: Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid
    Inventors: Juan Miguel Redondo Moya, Nerea Méndez-Barbero, Jorge Oller Pedrosa, Miguel Ramón Campanero García
  • IN VITRO METHOD FOR IDENTIFYING THORACIC AORTIC ANEURYSMS (TAA) IN A SUBJECT
    Publication number: 20190112582
    Abstract: The present invention refers to an In vitro method for screening for subjects at risk of developing thoracic aortic aneurysm (TAA) or a disease causing TAA comprising: (a) measuring the expression pattern or level of at least A Disintegrin And Metalloproteinase with Thrombospondin Motifs 1 (ADAMTS1) obtained from an isolated biological sample of the subjects to be screened; and (b) comparing said expression pattern or level of at least ADAMTS1 of the subjects to be screened with an already established expression pattern or level, wherein reduced expression of at least ADAMTS1 is indicative of a thoracic aortic aneurysm (TAA).
    Type: Application
    Filed: December 30, 2016
    Publication date: April 18, 2019
    Inventors: Juan Miguel REDONDO MOYA, Nerea MÉNDEZ-BARBERO, Jorge OLLER PEDROSA, Miguel Ramón CAMPANERO GARCÍA